Outcomes of infants born to persons infected with hepatitis B virus and managed by CDC Perinatal Hepatitis B Prevention Program, by birth cohort year —55 US Jurisdictions*, 2009–2019
Downloads of this figure: PDF PPT
Source: CDC, National Perinatal Hepatitis B Prevention Program.
Infants managed, number of infants case managed by the Perinatal Hepatitis B Prevention Program (PHBPP);
PEP (postexposure prophylaxis), number of infants who received PEP (hepatitis B immune globulin and 1st dose of hepatitis B vaccine) for hepatitis B infection; PVST (postvaccination serological testing), number of infants who received PVST after hepatitis B vaccine series completion.
*Includes 49 states and 6 cities. Excludes Washington state, territories, and freely associated island nations.
The number of infants managed in the Perinatal Hepatitis B Prevention Program from 49 states, District of Columbia, and 5 cities was 11,551 in 2009 and 8,995 in 2019 (Note: in 2019 Washington state did not report data). During 2009 to 2019, the percentage of infants managed who received PEP has remained relatively stable between 95% to 97% each year. The percentage of infants managed who received PSVT has increased from 59% (6,792 of 11,551 infants managed) in 2009 to 64% (5,753 of 8,995 infants managed) in 2019.